Acute promyelocytic leukemia (APL) is a biologically and clinically distinct subtype of acute myeloid leukemia (AML) characterized by the PML::RARA rearrangement resulting from the t(15;17)(q24;q21) translocation. This evidence concerns the gene PML and acute myeloid leukemia.